N-Acetyl Semax Amidate

Cognitive & neuro Research only Animal studies

Also called NA-Semax Amidate, Ac-MEHFPGP-NH2

Semax with protective caps on both ends — an acetyl group at one end, an amide at the other. The caps slow the enzymes that would otherwise chew it up, which is intended to extend how long it lasts, particularly when given nasally.

Evidence at a glance

Evidence
Animal studies — Not yet studied in people
Status
Research compound only
Dosing
No human study has set a dose

The capped form has far less direct research behind it than Semax itself — most claims are inferred from the parent peptide rather than demonstrated for this version.

What studies report

How it works

Same seven-residue core as Semax, raising BDNF in the brain, with terminal caps added to resist the exopeptidases that clear the parent peptide quickly.

Binds a receptor on the cell surface and signals inward

Where it acts

Brain

The library groups this compound under Cognitive & neuro. The diagram shows that target, not every tissue it reaches.

Illustrated

AI-generated subject illustration; not a depiction of the compound or evidence of its effects.

Why people take it

Focus and mental staminaMemoryLonger-lasting alternative to plain Semax

Reasons people seek it out — not a list of proven effects.

In practice Unapproved use

Reported real-world use, not evidence and not a recommendation.

Status: Research compound. Not approved.

Route
Intranasal spray
Sequence
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2
Formula
C39H54N10O10S
Molecular weight
855.0 g/mol
CAS
2920938-90-3
Available as
20 mg
View on PubChem →

Search PubMed for N-Acetyl Semax Amidate → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.